Neil Markham

Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.

S. D. Lee, Kenneth R. Shroyer, Neil Markham et al. · Journal of Clinical Investigation · 1998 · 428 citations · Full text

Medicine, Pathobiology, Pathology +16

Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure

Timothy D. Le Cras, Neil Markham, Rubin M. Tuder et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2002 · 380 citations

Medicine, Developmental Biology, Pharmacology +17

Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation

Kelly D. Sullivan, Donald L. Evans, Ahwan Pandey et al. · Scientific Reports · 2017 · 237 citations · Full text

Life Sciences, Genetics, Immunology +17

Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia

Vivek Balasubramaniam, Cela F. Mervis, Anne Maxey et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2007 · 236 citations

Life Sciences, Developmental Biology, Developmental Cell Biology +16

Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor

Jen‐Ruey Tang, Neil Markham, Yuh‐Jyh Lin et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2004 · 205 citations

Medicine, Pharmacology, Pharmacotherapy +17